[Sinovac Reports Unaudited Third Quarter Financial Results -- Conference call scheduled for Thursday, November 12, 2015 at 8:00 AM ET -- BEIJING, November 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter and nine month financial results for the period ended September 30, 2015. Third Quarter] []
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
[Form 6-K TABLE OF CONTENTS 3 4 2 WuXi PharmaTech (Cayman) Inc. Edward Hu Chief Financial Officer 3]
[Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results BEIJING, Nov. 2, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter, ended September 30, 2015, after the market closes on Wednesday, November 11, 2015. The] [Sinovac to Participate in Morgan Stanley Asia Pacific Summit th BEIJING, November 4, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the 14 About Sinovac www.sinovac.com Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines] []
[Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results BEIJING, Nov. 2, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter, ended September 30, 2015, after the market closes on Wednesday, November 11, 2015. The] [Sinovac to Participate in Morgan Stanley Asia Pacific Summit th BEIJING, November 4, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the 14 About Sinovac www.sinovac.com Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines] []
[Form 6-K TABLE OF CONTENTS 3 4 12 2 WuXi PharmaTech (Cayman) Inc. Edward Hu]
[Form 6-K TABLE OF CONTENTS 3 4 12 2 WuXi PharmaTech (Cayman) Inc. Edward Hu]
[Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate BEIJING, Oct. 26, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted] []
[Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate BEIJING, Oct. 26, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted] []
